Skip to main content
. 2014 Jun 6;2(5):827–832. doi: 10.3892/mco.2014.306

Table IV.

Response rate.

Response rate CR PR SD PD NE RR DCR
BBP− (n=27), n 0 0 7 8 12 0 7
% 0 0 25.9 29.6 44.4 0 25.9
BBP+ (n=15), n 1 0 9 2 3 1 10
% 6.7 0 60 13.3 20 6.7 66.7

CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; NE, not examined; RR, response rate; DCR, disease control rate; BBP, bevacizumab beyond progression.